Holen Sie sich die Stockscreener-App
0.821
2.94%
-0.0249
Handel nachbörslich:
.83
0.009
+1.10%
Schlusskurs vom Vortag:
$0.8459
Offen:
$0.818
24-Stunden-Volumen:
308.22K
Relative Volume:
0.28
Marktkapitalisierung:
$983.46K
Einnahmen:
$9.00M
Nettoeinkommen (Verlust:
$-7.21M
KGV:
-1.4927
EPS:
-0.55
Netto-Cashflow:
$-7.59M
1W Leistung:
-7.86%
1M Leistung:
-30.42%
6M Leistung:
-91.40%
1J Leistung:
-99.56%
1-Tages-Spanne:
$0.8017
$0.8499
1-Wochen-Bereich:
$0.79
$0.90
52-Wochen-Spanne:
$0.723
$236.00
Applied Dna Sciences Inc Stock (APDN) Company Profile
Firmenname
Applied Dna Sciences Inc
Sektor
Branche
Telefon
631-240-8800
Adresse
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Vergleichen Sie APDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.821 | 983.46K | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-02-12 | Eingeleitet | ROTH Capital | Buy |
| 2021-01-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-20 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-14 | Bestätigt | Maxim Group | Buy |
| 2016-05-13 | Bestätigt | Maxim Group | Buy |
| 2015-10-08 | Bestätigt | Maxim Group | Buy |
| 2015-05-26 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2015-02-10 | Bestätigt | Maxim Group | Buy |
| 2015-01-13 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Applied Dna Sciences Inc Aktie (APDN) Neueste Nachrichten
Applied Dna Sciences Inc (APDN)’s Day in Review: Closing at 0.85, Down by -2.41 - DWinneX
Applied DNA Sciences Inc expected to post a loss of $3.00 a shareEarnings Preview - TradingView
Geode Capital Management LLC Grows Holdings in Applied DNA Sciences, Inc. (NASDAQ:APDN) - Defense World
Applied Dna Sciences Inc (APDN) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Applied DNA Sciences (APDN) to Release Quarterly Earnings on Friday - Defense World
Investing in Applied Dna Sciences Inc (APDN) Is Getting More Attractive - knoxdaily.com
Ratios Revealed: Decoding Applied Dna Sciences Inc (APDN)’s Financial Health - DWinneX
Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World
Financial Analysis: Applied Dna Sciences Inc (APDN)’s Ratios Unveil Key Insights - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Analysts Say Applied Dna Sciences Inc (NASDAQ:APDN) Can Really Get To 1.5 In 12 Months - Marketing Sentinel
Applied Dna Sciences Inc [APDN] Investment Appeal on the Rise - knoxdaily.com
Market Highlights: Applied Dna Sciences Inc (APDN) Ends on a High Note at 0.90 - DWinneX
Applied Dna Sciences Inc (APDN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
APDN’s earnings estimates: Are they on track to meet expectations? - uspostnews.com
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genetic Medicine Platforms | APDN Stock News - GuruFocus
Applied DNA secures U.S. supply chain for key materials By Investing.com - Investing.com Canada
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genet - GuruFocus
Applied DNA secures U.S. supply chain for key materials - Investing.com
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA | APDN Stock News - GuruFocus
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - The Joplin Globe
US Biotech Leader LineaRx Transforms DNA Manufacturing with Major Domestic Supply Chain Shift - Stock Titan
APDN stock plunges to 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa
APDN stock plunges to 52-week low at $0.89 amid market challenges - Investing.com Canada
Applied DNA regains compliance with Nasdaq minimum bid price rule - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Applied DNA regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa
Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule - MarketScreener
Applied DNA Sciences regains Nasdaq compliance with stock price By Investing.com - Investing.com South Africa
Applied DNA regains Nasdaq compliance with bid price - Investing.com
Applied DNA Sciences regains Nasdaq compliance with stock price - Investing.com
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Weatherford Democrat
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan
APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low at $1.14 amid steep decline By Investing.com - Investing.com South Africa
Applied DNA sets May 22 for virtual shareholder meeting By Investing.com - Investing.com India
Applied DNA sets May 22 for virtual shareholder meeting - Investing.com
Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com
Why Applied DNA Sciences (APDN) Stock Is Rising - Benzinga
Applied DNA refines pharmacogenomics strategy By Investing.com - Investing.com Australia
Applied DNA refines pharmacogenomics strategy - Investing.com
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement - ACCESS Newswire
Critical FDA Safety Alert Powers Applied DNA's New Cancer Drug Testing Solution - Stock Titan
APDN stock plunges to 52-week low at $1.63 amid steep decline - Investing.com Canada
Finanzdaten der Applied Dna Sciences Inc-Aktie (APDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):